Osteopontin and Cancer: Insights into Its Role in Drug Resistance

被引：17
|
作者：
Hao, Chengcheng [1 ,2 ]
Lane, Jane [2 ]
Jiang, Wen G. [2 ]
机构：
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Oncol, Beijing 100038, Peoples R China
[2] Cardiff Univ, Div Canc & Genet, Cardiff China Med Res Collaborat, Sch Med, Heath Pk, Cardiff CF14 4XN, Wales
来源：
BIOMEDICINES | 2023年 / 11卷 / 01期
关键词：
osteopontin; cancer; drug resistance; molecular mechanism; LUNG-CANCER; EPIGENETIC MODIFICATIONS; EXPRESSION; CELLS; AUTOPHAGY; CISPLATIN; SENSITIVITY; BIOMARKER; HETEROGENEITY; MECHANISMS;
D O I：
10.3390/biomedicines11010197
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Cancer is one of the leading causes of mortality worldwide. Currently, drug resistance is the main obstacle in cancer treatments with the underlying mechanisms of drug resistance yet to be fully understood. Osteopontin (OPN) is a member of the integrin binding glycophosphoprotein family that is overexpressed in several tumour types. It is involved in drug transport, apoptosis, stemness, energy metabolism, and autophagy, which may contribute to drug resistance. Thus, understanding the role of OPN in cancer drug resistance could be important. This review describes the OPN-based mechanisms that might contribute to cancer drug resistance, demonstrating that OPN may be a viable target for cancer therapy to reduce drug resistance in sensitive tumours.
引用
收藏
页数：18
相关论文
共 50 条
  • [41] Role of osteopontin and its rs11730582 gene polymorphism in breast cancer
    Zakhary, Madeha M.
    Mahmoud, Aida A.
    Hashim, Marwa S.
    META GENE, 2018, 17 : 124 - 127
  • [42] Role of osteopontin in cancer development and treatment
    Yan, Zhihua
    Hu, Xue
    Tang, Bin
    Deng, Fengmei
    HELIYON, 2023, 9 (10)
  • [43] Role of osteopontin in breast cancer patients
    Macri, Antonio
    Versaci, Antonino
    Lupo, Giuseppe
    Trimarchi, Giuseppe
    Tomasello, Chiara
    Loddo, Saverio
    Sfuncia, Giuseppe
    Caminiti, Rocco
    Teti, Diana
    Famulari, Ciro
    TUMORI JOURNAL, 2009, 95 (01): : 48 - 52
  • [44] P-glycoprotein: Its role in drug resistance
    Ling, V
    AMERICAN JOURNAL OF MEDICINE, 1995, 99 : S31 - S34
  • [45] Insights into the critical role of the PXR in preventing carcinogenesis and chemotherapeutic drug resistance
    Niu, Xiaxia
    Wu, Ting
    Li, Gege
    Gu, Xinsheng
    Tian, Yanan
    Cui, Hongmei
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (02): : 742 - 759
  • [46] Mechanistic insights of NAC1 nuclear export and its role in ovarian cancer resistance to docetaxel
    Dong, ShunLi
    Wang, XiaoHui
    Yang, ShuMin
    Guo, FanFan
    Zhang, JingJing
    Ji, Cheng
    Shi, LiangRong
    Cheng, Yan
    Hu, YanWei
    Li, ZhenYun
    Peng, Lei
    Guo, LingChuan
    Zhu, WeiDong
    Ren, Xingcong
    Yang, Jin-Ming
    Zhang, Yi
    BIOCHEMICAL PHARMACOLOGY, 2023, 211
  • [47] The role of cancer cell bioenergetics in dormancy and drug resistance
    Tau, Steven
    Miller, Todd W.
    CANCER AND METASTASIS REVIEWS, 2023, 42 (01) : 87 - 98
  • [48] The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance
    Xavier, Cristina P. R.
    Caires, Hugo R.
    Barbosa, Melanie A. G.
    Bergantim, Rui
    Guimaraes, Jose E.
    Helena Vasconcelos, M.
    CELLS, 2020, 9 (05)
  • [49] The role of noncoding RNAs and sirtuins in cancer drug resistance
    Zahedipour, Fatemeh
    Jamialahmadi, Khadijeh
    Karimi, Gholamreza
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 877
  • [50] The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance
    Rudzinska, Magdalena
    Parodi, Alessandro
    Soond, Surinder M.
    Vinarov, Andrey Z.
    Korolev, Dmitry O.
    Morozov, Andrey O.
    Daglioglu, Cenk
    Tutar, Yusuf
    Zamyatnin, Andrey A., Jr.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (14)
12345